Deal Making in 2012- What Next? Part 1- Licensing




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Deal Making in 2012- What Next? Part 1- Licensing
Released on: May 21, 2012. © PharmaTelevision Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Part 1:In this episode Helen Wright talks to Fintan Walton,CEO PharmaVentures, Shaun Grady, VP Strategic Partnering Business Development, AstraZeneca and Andy Richards, BioTech Entrepreneur about the licensing environment in 2012
  • Summary
  • Transcript
  • Company
Part 1:In this episode Helen Wright talks to Fintan Walton,CEO PharmaVentures, Shaun Grady, VP Strategic Partnering Business Development, AstraZeneca and Andy Richards, BioTech Entrepreneur about the licensing environment in 2012
Part 1:In this episode Helen Wright talks to Fintan Walton,CEO PharmaVentures, Shaun Grady, VP Strategic Partnering Business Development, AstraZeneca and Andy Richards, BioTech Entrepreneur about the licensing environment in 2012
Pharmadeals
PharmaDeals is the publishing division of PharmaVentures. Whether you require data for benchmarking, competition analysis or simply to find out what new intellectual properties are being licensed, PharmaDeals gives you access to the latest deal making information in the pharmaceutical and biotech field. Intelligently indexed, the new PharmaDeals v4 database is the ultimate benchmarking tool. PharmaDeals also publishes a range of industry-leading reports, as well as PharmaDeals Review, the online serial with industry insight and analysis.